ABBOTT LABORATORIES

ABT · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $177.8B · 115,000 employees
132
SEC Filings
$100.3
Close 2026-04-10
115,000
Employees

Business Summary

Abbott Laboratories, incorporated in Illinois in 1900, discovers, develops, manufactures, and sells a broad line of healthcare products across four segments: Established Pharmaceutical Products (branded generics sold in emerging markets), Diagnostic Products (laboratory, molecular, and point-of-care systems), Nutritional Products (infant and adult nutrition such as Similac and Ensure), and Medical Devices (cardiovascular devices, FreeStyle Libre CGM, and neuromodulation products).

Latest Stock Quote

ABT 2026-04-10 $100.3 O:$102.71 H:$102.77 L:$99.34 Vol:11.9M VWAP:$100.3026
origin leaf: 8ca8fb39654348e2c1dd804dc815522cea6ce6240556c1a28508dcd50983ad9e

Next Earnings

Q2 FY2026 — expected 2026-07-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionABTdiscussed_in_filing Blockchain & Crypto
topic_mentionABTdiscussed_in_filing Healthcare & Bio
topic_mentionABTdiscussed_in_filing Platform & Ecosystem
topic_mentionABTdiscussed_in_filing Blockchain & Crypto
topic_mentionABTdiscussed_in_filing Healthcare & Bio
topic_mentionABTdiscussed_in_filing Platform & Ecosystem
topic_mentionABTdiscussed_in_filing Blockchain & Crypto
topic_mentionABTdiscussed_in_filing Healthcare & Bio
topic_mentionABTdiscussed_in_filing Platform & Ecosystem
topic_mentionABTdiscussed_in_filing Blockchain & Crypto
topic_mentionABTdiscussed_in_filing Healthcare & Bio
topic_mentionABTdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-202025-12-310001628280-26-010185EDGAR51K words
2025-02-212024-12-310001628280-25-007110EDGAR—
2024-02-162023-12-310001628280-24-005348EDGAR—
2023-02-172022-12-310001628280-23-004026EDGAR—
2022-02-182021-12-310001104659-22-025141EDGAR—
2021-02-192020-12-310001104659-21-025751EDGAR—
2020-02-212019-12-310001104659-20-023904EDGAR—
2019-02-222018-12-310001047469-19-000624EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-292025-09-300001628280-25-047131EDGAR16K words
2025-07-302025-06-300001628280-25-036720EDGAR—
2025-04-302025-03-310001628280-25-021090EDGAR—
2024-10-312024-09-300001628280-24-044602EDGAR—
2024-07-312024-06-300001628280-24-033740EDGAR—
2024-05-022024-03-310001628280-24-020011EDGAR—
2023-11-012023-09-300001628280-23-035957EDGAR—
2023-08-032023-06-300001628280-23-027203EDGAR—
2023-05-042023-03-310001628280-23-015699EDGAR—
2022-11-012022-09-300001628280-22-027550EDGAR—
2022-08-022022-06-300001628280-22-020209EDGAR—
2022-05-032022-03-310001104659-22-055285EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001104659-26-033079EDGAR1K words
2026-03-090001104659-26-025240EDGAR—
2026-02-260001104659-26-020509EDGAR—
2026-02-200001104659-26-018167EDGAR—
2026-01-220001628280-26-002982EDGAR—
2025-12-120001104659-25-120657EDGAR—
2025-11-210001104659-25-114995EDGAR—
2025-11-200001104659-25-114422EDGAR—
2025-10-150001628280-25-045049EDGAR—
2025-07-170001628280-25-035135EDGAR—

132 total filings indexed. 102 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC. AEON — AEON Biopharma, Inc.

Tags

emerging-markets-pharmaceutical clinical-and-hospital-laboratory-diagnostics molecular-diagnostics point-of-care-diagnostics rapid-diagnostics infant-nutrition adult-nutrition enteral-feeding cardiovascular-devices electrophysiology structural-heart heart-failure-management continuous-glucose-monitoring neuromodulation cancer-diagnostics pcr-(polymerase-chain-reaction) fish-(fluorescence-in-situ-hybridization) lateral-flow-testing burstdr-stimulation multipoint-pacing-technology pulsed-field-ablation

Company Identity

CIK0000001800
TickerABT
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedIL
Websitehttps://www.abbott.com
Listed1949-04-19

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 458205d26dea67dde4333399e234f5bc999d3a495d4f0682af4cdd9bce601525
parent: a79043379c3dc382599a9777d6f9b4adabaf017ff6e6d816cfa5dd15ae9560f3
content hash: d8299705f9c5747145c1ad891f9788c753b8ff4780975854b32909b656df4acb
signed: 2026-04-13T04:43:25.402Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf